Jump to content

PDRX - PD-Rx Pharmaceuticals


orion

Recommended Posts

Can't go too wrong with $2 / share in cash, a new policy of returning capital and $0.36 / share in earnings during a year with above-the-norm SG&A. I'm a simple man. Bought a few extra shares today. The opioid epidemic might cause some issues but there's a huge margin of safety.

Link to comment
Share on other sites

  • Replies 109
  • Created
  • Last Reply

Top Posters In This Topic

I looked at their 2017 report.  That line is exactly the same in 2017.  I am now thinking this was just a copy and paste error.  Microcaps..  Still in, but a little disappointed.

Yes, you are right. Looks like they were pretty lazy by copy and pasting the whole first paragraph...

 

They changed their annual report. They had first updated a different annual report (see attached). I was lucky to snoop around on their website on New Years holiday.

Overall it  was well written, appreciated the candor with respect to Opiods.  I am slightly offended that they removed it and did a copy-paste on the previous year, but its likely profits in 2019 will suffer.

 

They put the original version (with the additional info on opiods) back online.

Link to comment
Share on other sites

  • 11 months later...

Got some shares at $3.45. Surprised to be able to buy at NCAV. Long history of profitable operation, one year with a slight loss, history of returning significant cash to shareholders, aging management likely to consider selling, significant real estate ownership not included in NCAV.

Link to comment
Share on other sites

  • 1 year later...

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now



×
×
  • Create New...